
WELL Health Technologies Corp.
WELL Health Technologies Corp. (WELL.TO) Cash on Hand — Cash & Short-Term Investments
Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.
WELL.TO · cash on hand · updated Dec 31, 2025
Core cash position
as of Dec 31, 2025Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.
Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in CAD
Net cash vs debt
Cash vs Debt · Balance Sheet HealthWELL Health Technologies Corp. carries a net debt position of $577.2M. Total debt ($711.0M) exceeds cash on hand ($133.8M). WELL Health Technologies Corp. cash vs debt ratio: 16% cash / 84% debt.
Cash on hand history
Annual cash on hand by year
WELL.TO cash & short-term investments historyHealthcare Sector Cash Reserves Comparison
About cash on hand & methodology
WELL Health Technologies Corp. (WELL.TO) cash on hand as of December 31, 2025 is $133.8M, comprising $133.8M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as WELL Health Technologies Corp. cash and short-term investments on the balance sheet (10-K filing). Also referred to as WELL Health Technologies Corp. cash reserves or cash position.
WELL Health Technologies Corp. annual cash on hand history shows increased +1.6% in 2025: increased +1.6% in 2025. WELL Health Technologies Corp. cash reserves in 2025 reflect the company's capital allocation strategy.
WELL Health Technologies Corp. carries total debt of $711.0M against cash of $133.8M, resulting in a net debt position of -$577.2M. For the full balance sheet, see the Financials → Balance Sheet tab.
Frequently asked questions
WELL.TO cash on hand · 5 questionsAs of December 31, 2025, WELL Health Technologies Corp. (WELL.TO) has $133,755,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $133,755,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $134,002,000. Data sourced from the annual 10-K filing via FMP.
▸ Source: FMP /balance-sheet-statement · US GAAP · WELL Health Technologies Corp. · WELL Health Technologies Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025